Pharmala Biotech Holdings Inc C.MDMA

Alternate Symbol(s): MDXXF

PharmAla Biotech Holdings Inc. is a Canada-based biotechnology company. The Company is focused on the development, manufacture and sales of methylenedioxy methamphetamine (MDMA) and methylenedioxy phenethylamines (MDXX) class molecules in service to the burgeoning clinical research community and growing commercial use cases in select jurisdictions. The Company has three primary business lines: the manufacture of MDMA and MDXX class molecules for sale to clinical researchers in both the commercial and academic sphere, the research and development of novel MDXX class compounds which offer unique benefits above and beyond known substances, and the development of novel delivery mechanisms for MDMA and MDXX class compounds. Its research and development unit has completed proof-of-concept research into several IP families, including ALA-002, its lead drug candidate. It works with laboratories across Canada to develop novel processes for the supply of LaNeo MDMA and other MDXX substances.

CSE:MDMA - Post by User

Pharmala Biotech Holdings Inc

<< Previous

Bullboard Posts

Next >>

Post by Jackstockon Jun 12, 2023 9:08am

101 Views

Post# 35491242

One step ahead

Very good news for the US market. Many clinical trials will get underway there. Other country will follow, probably Canada and Brazil i guess. Pharmala position itself more and more within the last few months and its just the beginning :)

<< Previous

Bullboard Posts

Next >>

Calibre discovers significant gold in Newfoundland